Details of the Drug Reposition

General Information of This Drug (ID: DMH0QKA)

Drug Name
GDC-0199   DMH0QKA
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Approved [1]
Chronic lymphocytic leukaemia DISEXWC3 2A82.0 Approved [2]
------------------------------------------------------------------------------------

References

1 Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.Nat Rev Drug Discov. 2016 Aug;15(8):533-50.
2 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.